TBL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.505020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.775600E-02
Normal-vs-Stage2
1.428970E-01
Normal-vs-Stage3
6.393200E-01
Normal-vs-Stage4
1.464240E-01
Stage1-vs-Stage2
4.948800E-01
Stage1-vs-Stage3
1.889840E-01
Stage1-vs-Stage4
5.282200E-01
Stage2-vs-Stage3
2.251200E-01
Stage2-vs-Stage4
7.891600E-01
Stage3-vs-Stage4
2.292000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.610250E-01
Normal-vs-AfricanAmerican
2.968100E-02
Normal-vs-Asian
1.916430E-01
Caucasian-vs-AfricanAmerican
9.700600E-01
Caucasian-vs-Asian
5.346000E-01
AfricanAmerican-vs-Asian
5.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.790990E-01
Normal-vs-Female
1.254630E-01
Male-vs-Female
9.238400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.636960E-01
Normal-vs-Age(41-60Yrs)
7.988300E-02
Normal-vs-Age(61-80Yrs)
2.260600E-01
Normal-vs-Age(81-100Yrs)
5.723600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.138200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.699400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.538400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.548100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.332180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.203200E-01
Normal-vs-Daily Drinker
8.637900E-02
Normal-vs-Weekly Drinker
9.407500E-02
Normal-vs-Occasional Drinker
7.540100E-03
Normal-vs-Social Drinker
2.446400E-01
Non Drinker-vs-Daily Drinker
4.188200E-01
Non Drinker-vs-Weekly Drinker
8.924600E-01
Non Drinker-vs-Occasional Drinker
5.940200E-01
Non Drinker-vs-Social Drinker
3.600200E-01
Daily Drinker-vs-Weekly Drinker
5.305600E-01
Daily Drinker-vs-Occasional Drinker
6.329600E-01
Daily Drinker-vs-Social Drinker
6.542600E-01
Weekly Drinker-vs-Occasional Drinker
7.207800E-01
Weekly Drinker-vs-Social Drinker
4.078600E-01
Occasional Drinker-vs-Social Drinker
4.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.522000E-01
Normal-vs-Grade 2
8.080400E-01
Normal-vs-Grade 3
3.773600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.988000E-01
Grade 1-vs-Grade 3
9.476200E-01
Grade 1-vs-Grade 4
6.522000E-01
Grade 2-vs-Grade 3
1.528030E-01
Grade 2-vs-Grade 4
8.080400E-01
Grade 3-vs-Grade 4
3.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.826360E-01
Normal-vs-NonDiabetic
9.133500E-02
Diabetic-vs-NonDiabetic
1.043220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.254000E-02
Normal-vs-NoPancreatitis
1.276380E-01
Pancreatitis-vs-NoPancreatitis
2.829400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.456020E-01
Normal-vs-N1
1.666780E-01
N0-vs-N1
9.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.244600E-03
Normal-vs-TP53-NonMutant
2.574800E-01
TP53-Mutant-vs-TP53-NonMutant
5.419000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
